Circulating Biomarkers Repository in Adults Diagnosed With Primary and Metastatic Brain Tumors

Collection Of Tissue, Blood, and Other Specimens From Patients With Head and Neck Tumors To Study the Causes, Diagnosis, Prevention and Treatment of Cancers

NCT00580203 ·Status: COMPLETED

A Research Pilot Study in Healthy Volunteers to Evaluate Biomarkers for Novel Anticancer Treatments

NCT00586417 ·Status: TERMINATED ·Phase: NA

Biopsies of Cancer Patients for Tumor Molecular Characterization

NCT01061944 ·Status: COMPLETED

Detection of CSF Next Generation Sequencing in the Application of Brain Metastases From Lung Adenocarcinoma or Meningeal Metastasis

NCT03029065 ·Status: UNKNOWN

Collection of Retrospective (Archival) Samples and Prospective Collection of Surplus Tissue and Blood Samples

NCT02239575 ·Status: WITHDRAWN

CNS and Extracranial Tumor Tissues, CSF, and Blood From Patients With Melanoma Brain Metastases

NCT02058953 ·Status: COMPLETED

Biomarker Analysis of Central Nervous System Tumors

NCT02692898 ·Status: TERMINATED

Studying DNA in Tumor Tissue Samples From Patients With Localized or Metastatic Osteosarcoma

NCT01062438 ·Status: COMPLETED

Circulating Tumor DNA in Cerebrospinal Fluid as an Early Biomarker of Leptomeningeal Metastasis (LM)

NCT02071056 ·Status: COMPLETED

CIRculating CANcer MAster-Protocol

NCT05089747 ·Status: RECRUITING

Examining Blood and Tissue Samples to Identify Diagnostic Markers in Patients With Metastatic Cancer Undergoing Tumor Removal

NCT05530759 ·Status: RECRUITING

Collection of Cerebrospinal Fluid and Tumor Tissue in Subjects With Metastatic Melanoma and Controls

NCT01312506 ·Status: WITHDRAWN

Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer

NCT01137643 ·Status: RECRUITING

Study of Tissue and Blood Samples From Patients With High-Grade Glioma

NCT01004887 ·Status: COMPLETED

Identification of Secreted Markers for Tumor Hypoxia in Patients With Head and Neck or Lung Cancers

NCT00568490 ·Status: RECRUITING

Collection of Blood, Bone Marrow, Tumor, or Tissue Samples From Patients With Cancer to Study Drug Resistance

NCT00026663 ·Status: COMPLETED

Circulating Tumor DNA in Predicting Outcomes in Patients With Stage IV Head and Neck Cancer or Stage III-IV Non-small Cell Lung Cancer

NCT02245100 ·Status: COMPLETED

Biology Studies of Hematologic Cancers

NCT00923442 ·Status: ENROLLING_BY_INVITATION

Circulating Tumor Cells in Solid Tumors

NCT03161821 ·Status: COMPLETED

Validation of Molecular Diagnostic Assays to Detect Cancer Biomarkers in Blood and Primary Tumor in HNSCC/NSCLC/Melanoma

NCT04490564 ·Status: COMPLETED

Circulating Lymphatic Progenitor Cell and Lymph Node Metastasis

NCT01268956 ·Status: UNKNOWN

Study of Previously Collected and Stored Tissue Samples From Patients Previously Enrolled in a Completed National Cancer Institute Clinical Trial

NCT00904514 ·Status: TERMINATED

Study of Tissue and Blood Samples From Patients With Low-Grade Glioma

NCT01004523 ·Status: COMPLETED

Collection and Storage of Tissue and Blood Samples From Patients With Cancer

NCT02474160 ·Status: RECRUITING

Evaluation of Different Analysis Methods for Circulating Tumor Cells, Circulating Endothelial Cell, and Circulating Tumor DNA in Patient Followed for a Tumoral Pathology

NCT02220556 ·Status: COMPLETED ·Phase: NA